International Niemann–Pick Disease Alliance
Initial data support safety and tolerability of Trappsol® Cyclo™ administered intravenously (Available for download, here) ALACHUA, FL – (Marketwired) – 03/29/2018 – CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment...
Update #18 on the AIDNPC clinical programme (arimoclomol in treatment of Niemann-Pick disease type C) Available for download in English, German, French, Spanish, Italian, and Polish. Interim information bulletin (following the Dec. 28th call) SUMMARY 001 Study: Status...
Chin Huei Wu, gave a rousing presentation at the NPUK Annual Family Conference & Interactive Workshop (2017) in which he gave the story of his family’s life, living with Niemann-Pick disease: Subscribe to NPUK’s YouTube channel, to never miss...
ALACHUA, FL – (Marketwired) – December 6, 2017 – CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, today announced that it has received rare...
Available for download in English, French, German, Italian, Polish, and Spanish Dear Niemann-Pick type C Community, We are pleased to inform you that on November 16th Orphazyme A/S was listed on the Nasdaq OMX exchange in Copenhagen through an...
Medical geneticists at the Clinical Research Center of the Hospital de Clinicas in Porto Alegre are betting on an unprecedented treatment for a rare disease, known as ASMD Niemann-Pick disease type B. The disease has no cure, and causes...
We are happy to introduce the International Niemann-Pick Disease Registry (INPDR)’s official Facebook page – which will provide any and all relevant updates pertaining to the INPDR. But, what is the INPDR? The INPDR is a unifying force that has...
Update #17 on the AIDNPC Clinical Programme (arimoclomol in treatment of Niemann-Pick disease type C) Available for download in English, French, German, Italian, Polish & Spanish Interim information bulletin (following the Sept. 28th call) SUMMARY 001 Study: Conclusions and...
Two New Israeli Sites Now Recruiting Patients in Multicenter European Trial Full press release available for download here ALACHUA, FL – (Marketwired) – September 18, 2017 – CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company developing cyclodextrin-based...
We are sorry to share the sad news that Ara Parseghian, passed away yesterday. Ara was a former title winning coach of Notre Dame and founded the Ara Parseghian Medical Research Foundation, which has raised over $45million for research...